Publications for CA053996

	Publication Title (click to view publication in PubMed)*
1.	A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires' disease J Exp Med 2003 Nov 17 ;198(10):1563-1572
2.	A comparison of generalized linear mixed model procedures with estimating equations for variance and covariance parameter estimation in longitudinal studies and group randomized trials Stat Med 2001 Nov 30 ;20(22):3353-3373
3.	A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection Biostatistics 2003 Jul ;4(3):449-463
4.	A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies Am J Hum Genet 2003 May ;72(5):1231-1250
5.	A methodological issue in the analysis of second-primary cancer incidence in long-term survivors of childhood cancers Am J Epidemiol 2003 Dec 1 ;158(11):1108-1113
6.	An Automated Peak Identification/Calibration Procedure for High-Dimensional Protein Measures From Mass Spectrometers 2003 ;2003(4):242-248
7.	An adjustment to improve the bivariate survivor function repaired NPMLE Lifetime Data Anal 2005 Sep ;11(3):291-307
8.	An intervention study on screening for breast cancer among single African-American women aged 65 and older Prev Med 2002 May ;34(5):536-545
9.	Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation Biostatistics 2006 Jul ;7(3):339-354
10.	Aspects of the science of cancer prevention trials: lessons from the conduct and planning of clinical trials of a low-fat diet intervention among women Prev Med 1991 Jan ;20(1):147-157
11.	Assessing accuracy of mammography in the presence of verification bias and intrareader correlation Biometrics 2005 Mar ;61(1):259-268
12.	Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients Clin Chem 2002 Oct ;48(10):1835-1843
13.	Breast mammographic changes among women adopting a low-fat eating pattern J Natl Cancer Inst 1997 Apr 2 ;89(7):466-467
14.	Cancer prevention behaviors and socioeconomic status among Hispanics and non-Hispanic whites in a rural population in the United States Cancer Causes Control 2002 Oct ;13(8):719-728
15.	Chronic disease prevention: public health potential and research needs Stat Med 2004 Nov 30 ;23(22):3409-3420
16.	Clinical trials and observational studies to assess the chronic disease benefits and risks of multivitamin-multimineral supplements Am J Clin Nutr 2007 Jan ;85(1):308S-313S
17.	Correlation coefficient estimation of nutrient data under repeated measurements and restricted sampling [Chinese] Journal of Taiwan Intelligent Technologies and Applied Statistics 2004 ;2(1):33-50
18.	Data reduction using a discrete wavelet transform in discriminant analysis of very high dimensionality data Biometrics 2003 Mar ;59(1):143-151
19.	Design considerations for estimation of exposure effects on disease risk, using aggregate data studies Stat Med;15(17-18):1849-1858
20.	Dietary fat and cancer: rejoinder and discussion of research strategies Cancer Causes Control 1991 Jan ;2(1):53-58
21.	Dietary fat reduction as a hypothesis for the prevention of postmenopausal breast cancer, and a discussion of hypothesis testing research strategies Adv Exp Med Biol 1994 ;364():25-33
22.	Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers Prev Med 1991 Jan ;20(1):38-46
23.	Epidemiologic methods developments: a look forward to the year 2032 Ann Epidemiol 2007 Nov ;17(11):906-910
24.	Estimating equations for parameters in means and covariances of multivariate discrete and continuous responses Biometrics 1991 Sep ;47(3):825-839
25.	Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms Biostatistics 2003 Oct ;4(4):513-522
26.	Evaluation of an outreach intervention to promote cervical cancer screening among Cambodian American women Cancer Detect Prev 2002 ;26(4):320-327
27.	Evaluation of community-intervention trials via generalized linear mixed models Biometrics 2004 Dec ;60(4):1043-1052
28.	Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility Clin Chem 2005 Jan ;51(1):102-112
29.	Exploring interactions in high dimensional genomic data: an overview of Logic Regression, with applications J Multivar Anal 2004 ;90(1):178-195
30.	Future possibilities in the prevention of breast cancer: fat and fiber and breast cancer research Breast Cancer Res 2000 ;2(4):268-276
31.	Identifying interacting SNPs using Monte Carlo logic regression Genet Epidemiol 2005 Feb ;28(2):157-170
32.	Identifying settings when permutation tests have nominal size with paired, binary-outcome, group randomized trials Journal of Nonparametric Statistics 2003 Dec ;15(6):653-663
33.	Implementation of the Women's Health Initiative study design Ann Epidemiol 2003 Oct ;13(9 Suppl):S5-17
34.	Individually randomized intervention trials for disease prevention and control Stat Methods Med Res 1999 Dec ;8(4):287-309
35.	Integrated designs for gene discovery and characterization J Natl Cancer Inst Monogr 1999 ;(26):71-80
36.	Integrating the predictiveness of a marker with its performance as a classifier Am J Epidemiol 2008 Feb 1 ;167(3):362-368
37.	Invited commentary: ethics and sample size--another view Am J Epidemiol 2005 Jan 15 ;161(2):111-112
38.	Linear measurement error models with restricted sampling Biometrics 2007 Mar ;63(1):137-142
39.	Logistic regression with exposure biomarkers and flexible measurement error Biometrics 2007 Mar ;63(1):143-151
40.	Measurement error and results from analytic epidemiology: dietary fat and breast cancer J Natl Cancer Inst 1996 Dec 4 ;88(23):1738-1747
41.	Methodologic research needs in environmental epidemiology: data analysis Environ Health Perspect 1993 Dec ;101 Suppl 4():39-48
42.	Mixed discrete and continuous Cox regression model Lifetime Data Anal 2003 Jun ;9(2):195-210
43.	Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials Clin Trials 2007 ;4(3):207-217
44.	Nonparametric correction for covariate measurement error in a stratified Cox model Biostatistics 2004 Jan ;5(1):75-87
45.	Nutrition and physical activity and chronic disease prevention: research strategies and recommendations J Natl Cancer Inst 2004 Sep 1 ;96(17):1276-1287
46.	On non-parametric maximum likelihood estimation of the bivariate survivor function Stat Med;18(17-18):2517-2527
47.	On the accommodation of disease rate correlations in aggregate data studies of disease risk factors Biometrics 1998 Dec ;54(4):1527-1540
48.	On the assessment of statistical significance in disease-gene discovery Am J Hum Genet 1999 Jun ;64(6):1739-1753
49.	On the catch-up time method for analyzing cancer screening trials Biometrics 1995 Mar ;51(1):31-43
50.	On the reliability and precision of within- and between- population estimates of relative rate parameters Biometrics 1995 Sep ;51(3):853-863
51.	On the role, design, and analysis of disease prevention trials Control Clin Trials 1995 Aug ;16(4):249-258
52.	Optimal permutation tests for the analysis of group randomized trials J Am Stat Assoc 2001 Dec 1 ;96(456):1424-1432
53.	Partially supervised learning using an EM-boosting algorithm Biometrics 2004 Mar ;60(1):199-206
54.	Participant characteristics associated with errors in self-reported energy intake from the Women's Health Initiative food-frequency questionnaire Am J Clin Nutr 2002 Oct ;76(4):766-773
55.	Performance of the log-linear approach to case-parent triad data for assessing maternal genetic associations with offspring disease: type I error, power, and bias Am J Epidemiol 2005 Jan 15 ;161(2):196-204
56.	Phases of biomarker development for early detection of cancer J Natl Cancer Inst 2001 Jul 18 ;93(14):1054-1061
57.	Prostate-specific antigen and free prostate-specific antigen in the early detection of prostate cancer: do combination tests improve detection? Cancer Epidemiol Biomarkers Prev 2004 Oct ;13(10):1640-1645
58.	Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit Fertil Steril 2005 Apr ;83(4):853-854
59.	Regression calibration in failure time regression Biometrics 1997 Mar ;53(1):131-145
60.	Regression estimation using multivariate failure time data and a common baseline hazard function model Lifetime Data Anal 1997 ;3(3):197-213
61.	Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective Pharmacogenomics 2004 Sep ;5(6):709-719
62.	Research strategies and the use of nutrient biomarkers in studies of diet and chronic disease Public Health Nutr 2002 Dec ;5(6A):977-984
63.	Seattle 5 a Day worksite program to increase fruit and vegetable consumption Prev Med 2001 Mar ;32(3):230-238
64.	Selected statistical issues in group randomized trials Annu Rev Public Health 2001 ;22():167-187
65.	Semiparametric estimation of time-dependent ROC curves for longitudinal marker data Biostatistics 2004 Oct ;5(4):615-632
66.	Some design issues in a community intervention trial Control Clin Trials 2002 Aug ;23(4):431-449
67.	Some further results on incorporating risk factor information in assessing the dependence between paired failure times arising from case-control family studies: an application to prostate cancer Stat Med 2002 Mar 30 ;21(6):863-876
68.	Statistical considerations in combining biomarkers for disease classification Dis Markers 2004 ;20(2):45-51
69.	Statistical issues arising in the Women's Health Initiative Biometrics 2005 Dec ;61(4):899-911
70.	Statistical modeling of large microarray data sets to identify stimulus-response profiles Proc Natl Acad Sci U S A 2001 May 8 ;98(10):5631-5636
71.	Statistical models for the analysis of ordered categorical data in public health and medical research Stat Methods Med Res 1994 ;3(2):179-204
72.	Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research Stat Med 1994 May 15 ;13(9):955-968
73.	Survival model predictive accuracy and ROC curves Biometrics 2005 Mar ;61(1):92-105
74.	Tumor marker utility grading system J Natl Cancer Inst 1996 Oct 16 ;88(20):1419-1420